• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多组学综合分析肝内黏液性胆管癌的起源:一例报告

Multi-omics integrated analyzed the origin of intrahepatic mucinous cholangiocarcinoma: a case report.

作者信息

Zeng Xiaokang, Ou Huohui, Zeng Chong, Liu Qingbo, Wang Weidong, Yao Jie

机构信息

Medical Research Center, Shunde Hospital, Southern Medical University, Foshan, China.

Department of Hepatobiliary Surgery, Shunde Hospital, Southern Medical University, Foshan, China.

出版信息

Front Oncol. 2023 Jul 21;13:1175707. doi: 10.3389/fonc.2023.1175707. eCollection 2023.

DOI:10.3389/fonc.2023.1175707
PMID:37546424
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10401833/
Abstract

Intrahepatic mucinous cholangiocarcinoma (IMCC) is a rare subtype of intrahepatic cholangiocarcinoma (IHCC). Limited data describe the genetic characteristics of IMCC and insights on its pathogenesis are lacking. Here, we employed a multi-omics approach to analyze somatic mutations, transcriptome, proteome and metabolome of tumor tissue obtained from a case of IMCC in order to clarify the pathogenesis of IMCC. A total of 54 somatic mutations were detected, including a G12D mutation in KRAS that is likely to be involved in the onset of IMCC. The genes consistently up-regulated at the transcription level and in the proteome were enriched for mucin and mucopolysaccharide biosynthesis, for cell cycle functions and for inflammatory signaling pathways. The consistently down-regulated genes were enriched in bile synthesis and fatty acid metabolism pathways. Further multi-omics analysis found that mucin synthesis by MUC4 and MUC16 was elevated by up-regulated expression of mesothelin (MSLN). Moreover, transcription factor ONECUT3 was identified that possibly activates the transcription of mucin and mucopolysaccharide biosynthesis in IMCC.

摘要

肝内黏液性胆管癌(IMCC)是肝内胆管癌(IHCC)的一种罕见亚型。关于IMCC基因特征的数据有限,且缺乏对其发病机制的深入了解。在此,我们采用多组学方法分析了一例IMCC患者肿瘤组织的体细胞突变、转录组、蛋白质组和代谢组,以阐明IMCC的发病机制。共检测到54个体细胞突变,其中KRAS基因的G12D突变可能与IMCC的发病有关。在转录水平和蛋白质组中持续上调的基因在黏蛋白和黏多糖生物合成、细胞周期功能及炎症信号通路方面富集。持续下调的基因在胆汁合成和脂肪酸代谢途径中富集。进一步的多组学分析发现,间皮素(MSLN)表达上调使MUC4和MUC16的黏蛋白合成增加。此外,还鉴定出转录因子ONECUT3,其可能激活IMCC中黏蛋白和黏多糖生物合成的转录。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1293/10401833/05b757cc8ebf/fonc-13-1175707-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1293/10401833/4637cb40893f/fonc-13-1175707-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1293/10401833/96c046017b11/fonc-13-1175707-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1293/10401833/05b757cc8ebf/fonc-13-1175707-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1293/10401833/4637cb40893f/fonc-13-1175707-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1293/10401833/96c046017b11/fonc-13-1175707-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1293/10401833/05b757cc8ebf/fonc-13-1175707-g003.jpg

相似文献

1
Multi-omics integrated analyzed the origin of intrahepatic mucinous cholangiocarcinoma: a case report.多组学综合分析肝内黏液性胆管癌的起源:一例报告
Front Oncol. 2023 Jul 21;13:1175707. doi: 10.3389/fonc.2023.1175707. eCollection 2023.
2
CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study.基于 CT 的临床-影像学列线图预测肝内肿块型胆管细胞癌患者的预后:一项多中心研究。
Eur Radiol. 2022 Dec;32(12):8326-8338. doi: 10.1007/s00330-022-08914-0. Epub 2022 Jun 16.
3
DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.基于 DCE-MRI 的影像组学列线图用于术前鉴别肝细胞癌-胆管细胞癌混合型与肿块型肝内胆管细胞癌。
Eur Radiol. 2022 Jul;32(7):5004-5015. doi: 10.1007/s00330-022-08548-2. Epub 2022 Feb 7.
4
Mass-forming intrahepatic cholangiocarcinoma: Can diffusion-weighted imaging predict microvascular invasion?巨块型肝内胆管细胞癌:弥散加权成像能否预测微血管侵犯?
J Magn Reson Imaging. 2019 Jul;50(1):315-324. doi: 10.1002/jmri.26566. Epub 2018 Nov 15.
5
Optimizing CT and MRI criteria for differentiating intrahepatic mass-forming cholangiocarcinoma and hepatocellular carcinoma.优化CT和MRI标准以鉴别肝内肿块型胆管癌和肝细胞癌。
Acta Radiol. 2023 Mar;64(3):926-935. doi: 10.1177/02841851221113265. Epub 2022 Jul 27.
6
Role of Intravoxel Incoherent Motion in Discriminating Hepatitis B Virus-Related Intrahepatic Mass-Forming Cholangiocarcinoma from Hepatocellular Carcinoma Based on Liver Imaging Reporting and Data System v2018.基于 Liver Imaging Reporting and Data System v2018,体素内不相干运动在鉴别乙型肝炎病毒相关肝内肿块型胆管细胞癌与肝细胞癌中的作用。
Cancer Biother Radiopharm. 2019 Oct;34(8):511-518. doi: 10.1089/cbr.2019.2799. Epub 2019 Jul 16.
7
Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma.Kras(G12D)和 p53 突变导致原发性肝内胆管癌。
Cancer Res. 2012 Mar 15;72(6):1557-67. doi: 10.1158/0008-5472.CAN-11-3596. Epub 2012 Jan 20.
8
Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.肝内胆管癌的空间和时间克隆进化。
J Hepatol. 2018 Jul;69(1):89-98. doi: 10.1016/j.jhep.2018.02.029. Epub 2018 Mar 16.
9
Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.水通道蛋白-1在肝内胆管癌中的下调与肿瘤进展及黏蛋白表达有关。
Hum Pathol. 2007 Dec;38(12):1819-25. doi: 10.1016/j.humpath.2007.04.016. Epub 2007 Sep 14.
10
Two classes of intrahepatic cholangiocarcinoma defined by relative abundance of mutations and copy number alterations.根据突变相对丰度和拷贝数改变定义的两类肝内胆管癌。
Oncotarget. 2016 Apr 26;7(17):23825-36. doi: 10.18632/oncotarget.8183.

引用本文的文献

1
Recent Advances in Pathology of Intrahepatic Cholangiocarcinoma.肝内胆管癌病理学的最新进展
Cancers (Basel). 2024 Apr 17;16(8):1537. doi: 10.3390/cancers16081537.
2
Identification of ONECUT3 as a stemness-related transcription factor regulating NK cell-mediated immune evasion in pancreatic cancer.鉴定 ONECUT3 作为一种与干性相关的转录因子,调节胰腺癌中 NK 细胞介导的免疫逃逸。
Sci Rep. 2023 Oct 24;13(1):18133. doi: 10.1038/s41598-023-45560-y.

本文引用的文献

1
A bile acid-related prognostic signature in hepatocellular carcinoma.胆汁酸相关的肝癌预后标志物。
Sci Rep. 2022 Dec 26;12(1):22355. doi: 10.1038/s41598-022-26795-7.
2
Therapeutic high affinity T cell receptor targeting a KRAS cancer neoantigen.靶向 KRAS 癌症新抗原的治疗性高亲和力 T 细胞受体。
Nat Commun. 2022 Sep 10;13(1):5333. doi: 10.1038/s41467-022-32811-1.
3
The altered lipidome of hepatocellular carcinoma.肝细胞癌的脂质组改变。
Semin Cancer Biol. 2022 Nov;86(Pt 3):445-456. doi: 10.1016/j.semcancer.2022.02.004. Epub 2022 Feb 4.
4
Intraductal papillary mucinous neoplasm of the biliary tract with cardiac metastasis: A case report.伴有心脏转移的胆管内乳头状黏液性肿瘤:一例报告
Medicine (Baltimore). 2021 Jan 22;100(3):e24310. doi: 10.1097/MD.0000000000024310.
5
KRAS G12D mutation predicts lower TMB and drives immune suppression in lung adenocarcinoma.KRAS G12D突变预示着肺腺癌中较低的肿瘤突变负荷并驱动免疫抑制。
Lung Cancer. 2020 Nov;149:41-45. doi: 10.1016/j.lungcan.2020.09.004. Epub 2020 Sep 10.
6
Pathological aspects of mucinous cholangiocarcinoma: A single-center experience and systematic review.黏液型胆管细胞癌的病理学特征:单中心经验与系统综述。
Pathol Int. 2020 Sep;70(9):661-670. doi: 10.1111/pin.12983. Epub 2020 Jul 7.
7
Genomic and Transcriptomic Landscape of Tumor Clonal Evolution in Cholangiocarcinoma.胆管癌肿瘤克隆进化的基因组和转录组图谱
Front Genet. 2020 Mar 13;11:195. doi: 10.3389/fgene.2020.00195. eCollection 2020.
8
The 2019 WHO classification of tumours of the digestive system.2019年世界卫生组织消化系统肿瘤分类。
Histopathology. 2020 Jan;76(2):182-188. doi: 10.1111/his.13975. Epub 2019 Nov 13.
9
Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis.胆管癌:分类、组织病理学和分子发生机制。
Pathol Oncol Res. 2020 Jan;26(1):3-15. doi: 10.1007/s12253-018-0491-8. Epub 2018 Nov 17.
10
Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type.肝内胆管癌的出现:高通量技术如何加速解决一种罕见癌症类型的问题。
Front Genet. 2018 Aug 15;9:309. doi: 10.3389/fgene.2018.00309. eCollection 2018.